10times
Conference

International Conference on Vaccines Research and Development

12 - 14 Oct 2020 New Date Reminder
Radisson Hotel Baltimore Downtown-Inner Harbor, Baltimore, USA
AboutFollowers 10ReviewsExhibitorsPhotosSpeakers 30Travel Deals
Check International Conference on Vaccines Research & Development happening in Boston, USA on 01 - 03 Nov 2021
Speakers (Nov 2015)
Speaker
Alan S Cross

Alan S Cross

prof. at University of Maryland at Baltimore, USABaltimore, USA
Speaker
Ali Fattom

Ali Fattom

Vice President at NanoBioWashington DC, USA
Speaker
Amita Joshi

Amita Joshi

prof. at Merck & Co, USAWarwick, UK
Speaker
Andy Geall

Andy Geall

Platform Leader at Novartis Vaccines, Inc.Boston, USA
Speaker
Andrew Lees

Andrew Lees

Scientific Director at Fina BioSolutions LLC, University of Maryland, Baltimore (UMB)Washington DC, USA
Speaker
Armando Zuniga

Armando Zuniga

prof. at Virometix AG, SwitzerlandZürich, Switzerland
Speaker
Arnaldo Caruso

Arnaldo Caruso

prof. at University of Brescia Medical School, ItalyBrescia, Italy
Speaker
Barbara K. Felber

Barbara K. Felber

Chied, Human Retrovirus Pathogenesis section at National Cancer Institute, International AIDS Vaccine InitiativeWashington DC, USA
Speaker
Barry Buckland

Barry Buckland

CEO at BiologicBPhiladelphia, USA
Speaker
Bernadette Ferraro

Bernadette Ferraro

R&D Scientist at Inovio Pharmaceuticals Inc.San Diego, USA
Speaker
Betsy C. Herold

Betsy C. Herold

Vaccines for HSV prevention: Rethinking the role of neutralizing antibodies at Albert Einstein College of Medicine, USACalifornia City, USA
Speaker
Brian J. Czerniecki

Brian J. Czerniecki

Professor of Surgery, Co-Director of Rowan Breast Center at University of Pennsylvania, Hospital of the University of PennsylvaniaPhiladelphia, USA
Speaker
Carmen Alvarez-Dominguez

Carmen Alvarez-Dominguez

prof. at Instituto de Investigacion Marques de Valdecilla, SpainSabadell, Spain
Speaker
Cécile BAUCHE

Cécile BAUCHE

CSO at THERAVECTYSParis, France
Speaker
Charani Ranasinghe

Charani Ranasinghe

Fellow & Group Leader at Australian National UniversityCanberra, Australia
Speaker
Christopher Heery

Christopher Heery

Staff Clinician at National Cancer InstituteWashington DC, USA
Speaker
Chul-Joong Kim

Chul-Joong Kim

Editoreal at Chosun MediaSeoul, South Korea
Speaker
Daniel H Zimmerman

Daniel H Zimmerman

prof. at CEL-SCI Corporation, USACalifornia City, USA
Speaker
De-chu Christopher Tang

De-chu Christopher Tang

Founder; VaxDome LLC & Vaxin Inc. at VaxDome LLCBirmingham, USA
Speaker
Denise L Faustman

Denise L Faustman

prof. at Harvard Medical School, USABoston, USA
Speaker
Dennis Klinman

Dennis Klinman

Senior Investigator at National Cancer InstituteWashington DC, USA
Speaker
Diane Williamson

Diane Williamson

prof. at Defence Science & Technology Laboratory, UKLondon, Canada
Speaker
Douglas E. Brough

Douglas E. Brough

Chief Scientific Officer at GenVecWashington DC, USA
Speaker
Duane A. Mitchell

Duane A. Mitchell

Co-Director at University of FloridaFlorida City, USA
Speaker
Eelko Hak

Eelko Hak

prof. at University of Groningen, The NetherlandsAmsterdam, Netherlands
Speaker
Emmanuel Drouet

Emmanuel Drouet

UVHCI, UMI 3265 UJF-EMBL-CNRS, 6 rue Jules Horowitz at Floralis, Université Joseph Fourier, Grenoble I, FranceParis, France
Speaker
Eric Aubin

Eric Aubin

prfo. at Medicago, USAUSA
Speaker
Geert Vanden Bossche

Geert Vanden Bossche

Vaccine Research and Development Consultant at VaReCo, Positions in AcademiaAntwerp, Belgium
Speaker
Genevieve G Fouda Amouou

Genevieve G Fouda Amouou

Assistant Professor at Duke UniversityRaleigh, USA
Speaker
George N Pavlakis

George N Pavlakis

Senior Executive for Revenue Cycle Management/Reimbursement at Pavlakis & AssociatesCincinnati, USA